Renal function following kidney transplantation in children treated with cyclosporine

U B Berg1, A B Bohlin

  • 1Department of Paediatrics, Karolinska Institute, Huddinge University Hospital, Sweden.

Insights

Pediatric kidney transplant recipients on cyclosporine show reduced long-term renal function, with lower glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) compared to controls.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Transplantation Immunology

Background:

  • Cyclosporine is a key immunosuppressant in pediatric kidney transplantation.
  • Long-term renal function outcomes in these patients require thorough evaluation.

Purpose of the Study:

  • To assess the long-term renal function in children post-kidney transplantation treated with cyclosporine.
  • To compare renal function between transplanted children and a control group with solitary native kidneys.

Main Methods:

  • Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured using inulin and aminohippurate sodium clearances.
  • Thirty-six pediatric kidney transplant recipients were followed yearly for up to 7.1 years.
  • A control group of 25 children and young adults with solitary kidneys was included for comparison.

Main Results:

  • Transplanted children had significantly lower GFR and ERPF within one year compared to controls.
  • While GFR remained stable, ERPF significantly decreased over four years post-transplantation.
  • Reduced GFR correlated inversely with cyclosporine concentration and rejection episodes; hypertension decreased over time.

Conclusions:

  • Kidney transplantation in children leads to diminished renal function compared to solitary native kidneys.
  • Cyclosporine load and rejection episodes negatively impact renal function.
  • An increase in absolute GFR suggests potential for growth and compensatory hypertrophy post-transplant.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...